The effects of abdominal and bimanual pelvic examination and transvaginal ultrasonography on serum CA-125 levels

Basit Öğe Kaydı
dc.authorscopusid18838208900
dc.authorscopusid7004682700
dc.authorscopusid7005479833
dc.authorscopusid57196683829
dc.authorscopusid7004200793
dc.authorscopusid6603259204
dc.authorscopusid21642842600
dc.contributor.authorSari R.
dc.contributor.authorBuyukberber S.
dc.contributor.authorSevinc A.
dc.contributor.authorAtes M.
dc.contributor.authorBalat O.
dc.contributor.authorHascalik S.
dc.contributor.authorTurk M.
dc.date.accessioned2024-08-04T19:59:29Z
dc.date.available2024-08-04T19:59:29Z
dc.date.issued2000
dc.departmentİnönü Üniversitesien_US
dc.description.abstractThe need for the early detection of ovarian cancer continues to be one of the most important issues in women's health care. The three most extensively evaluated screening methods for ovarian cancer are pelvic examination, transvaginal ultrasonography, and serum CA-125 levels. The answers to questions such as should the levels of CA-125 be measured before bimanual pelvic examination or transvaginal ultrasonography or do abdominal examinations effect the levels of CA-125 are obscure. Fifty-four otherwise healthy female volunteers at the preovulatory phase of the menstrual cycle complaining of vaginal candidiasis were divided into 3 groups. Abdominal (group 1), bimanual pelvic (group 2), and transvaginal ultrasonography (group 3) examination was performed and serum CA-125 levels were evaluated prior to examination and 10 minutes, 6 hours, and 24 hours after the examination. As a result, serum CA-125 levels (U/ml) were found to be 8.13 ± 4.76, 8.23 ± 5.05, 8.32 ± 4.88, and 8.33 ± 4.94 in the group of abdominal examination, respectively, 8.23 ± 4.89, 8.45 ± 5.15, 8.77 ± 4.96, and 8.79 ± 5.50 in the group of bimanual pelvic examination, respectively, and 8.19 ± 4.56, 8.30 ± 5.10, 8.81 ± 5.56, and 8.88 ± 5.71 in the group of transvaginal ultrasonography, respectively. The serum CA-125 levels detected prior to examinations were statistically insignificant when compared with the results obtained at 10 minutes, 6 hours, and 24 hours later in all three groups. We concluded that physical examination, either abdominal or pelvic, and transvaginal ultrasonography do not change the serum levels of CA-125.en_US
dc.identifier.endpage71en_US
dc.identifier.issn0390-6663
dc.identifier.issue1en_US
dc.identifier.pmid10758808en_US
dc.identifier.scopus2-s2.0-0034063314en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage69en_US
dc.identifier.urihttps://hdl.handle.net/11616/90645
dc.identifier.volume27en_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.relation.ispartofClinical and Experimental Obstetrics and Gynecologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectFrozen shoulder syndromeen_US
dc.subjectKanzoen_US
dc.subjectMenopauseen_US
dc.subjectShakuyakuen_US
dc.titleThe effects of abdominal and bimanual pelvic examination and transvaginal ultrasonography on serum CA-125 levelsen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu